Exposure‐Response to SC Ustekinumab In Moderate‐Severe Crohn's Disease: Results From the IM‐UNITI Maintenance Study: 660. (October 2017) - Adedokun, Omoniyi J.; Xu, Zhenhua; Gasink, Christopher; Jacobstein, Douglas; Szapary, Philippe; Johanns, Jewel; Gao, Long Long; Davis, Hugh M.; Hanauer, Stephen; Feagan, Brian G.; Ghosh, Subrata; Sandborn, William J.